NCT04913272View on ClinicalTrials.gov

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

PHASE2SuspendedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Kidney Disease stage4
Interventions
DRUG

US-APR2020

US-APR2020 capsules 45 billion CFUs of the LBT.

DRUG

Placebo

Placebo

Trial Locations (5)

20904

Jadedstone Clinical Research, Silver Spring

22192

Mendez Center for Clinical Research, Woodbridge

29118

South Carolina Clinical Research, Orangeburg

48604

Kidney Michigan, Saginaw

77058

Almeda Medical Clinic, Houston

Sponsors

Lead Sponsor

Kibow Pharma
All Listed Sponsors
lead

Kibow Pharma

INDUSTRY